2-(2-BroMophenyl)propanoic acid(153184-13-5)
- Name: 2-(2-BroMophenyl)propanoic acid
- Synonyms:2-(o-bromophenyl)propionic acid;2-(2-bromophenyl)propionic acid;
- Molecular Formula:C9H9BrO2
- Molecular Weight:229.073
- CAS Registry Number:153184-13-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.153184-13-5 2-(2-Bromophenyl)propanoic acid
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.153184-13-5 Benzeneacetic acid, 2-bromo-a-methyl-
Assay:95% Application:Synthetic building block
Min. Order:0
Supplier:SAGECHEM LIMITED [
China (Mainland)]
Other Product
- 153182-32-2/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,4,7-tris(phenylmethyl)-3-(2-propenyl)-, (4R,5S,6S,7R)-
- 153182-44-6/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis[(3-methoxyphenyl)methyl]-4,7-bis(phen ylmethyl)-, (4R,5S,6S,7R)-
- 153183-03-0/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis[(3-hydroxyphenyl)methyl]-4,7-bis(phen ylmethyl)-, (4R,5S,6S,7R)-
- 153183-10-9/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis[(4-hydroxyphenyl)methyl]-4,7-bis(phen ylmethyl)-, (4R,5S,6S,7R)-
- 153183-38-1/2H-1,3-Diazepin-2-one, 1,3-bis[(3-acetylphenyl)methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenyl methyl)-, (4R,5S,6S,7R)-
- 153183-39-2/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis[[3-[1-(hydroxyimino)ethyl]phenyl]methyl ]-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-
- 153183-43-8/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-1,3-bis[[3-(1H-tetrazol-5 -yl)phenyl]methyl]-, (4R,5S,6S,7R)-
- 153183-53-0/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1-[(3-hydroxyphenyl)methyl]-3-(2-naphthalenyl methyl)-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-
- 153184-13-5/2-(2-BroMophenyl)propanoic acid
- 153195-28-9/Benzamide, N-hydroxy-N,3-dimethyl-
- 153198-03-9/Carbamic acid, [(3-endo)-9-(phenylmethyl)-9-azabicyclo[3.3.1]non-3-yl]-, 1,1-dimethylethyl ester
- 153198-06-2/Tert-Butyl 4-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate
- 153199-19-0/Benzonitrile, 4-(octylthio)-
- 153199-54-3/3-Pyridinol,4-methoxy-(9CI)
- 153201-81-1/Benzenemethanol, a-[1-amino-3-(methylthio)propyl]-4-methyl-a-(4-methylphenyl)-, (S)-
- 153201-82-2/Benzenemethanol, a-[1-amino-3-(methylthio)propyl]-4-methoxy-a-(4-methoxyphenyl)-, (S)-
- 153201-91-3/1-Cyclohexene-1-carbonitrile, 4,4-dimethyl-2-(4-morpholinyl)-6-oxo-
- 153201-92-4/1-Cyclohexene-1-carbonitrile, 4,4-dimethyl-2-(4-morpholinyl)-6-thioxo-
- 153205-42-6/Strontium, ethyliodo-
- 153205-82-4/2-Propanol, 2-methyl-, dihydrate
- 15321-08-1/Chlorate(1-), difluoro-, rubidium
- 153212-60-3/[1]Benzopyrano[4,3-c]pyrazol-4(2H)-one, 2,3-dimethyl-
- 153212-73-8/Propanedioic acid, (acetylamino)[2-(3-nitrophenyl)-2-oxoethyl]-, diethyl ester
- 153215-72-6/1,6-Naphthalenediol, 5,6,7,8-tetrahydro-7-(4-phenyl-1-piperidinyl)-, (6R,7R)-
- 1532-17-8/Pyridinium, 1-[[(diphenylamino)carbonyl]oxy]-4-methyl-, chloride
- 153218-97-4/Isoquinoline, 1,2,3,4-tetrahydro-4-phenyl-, (4S)-
- 153183-02-9/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1-(2-naphthalenylmethyl)-4,7-bis(phenylmethyl )-3-(3-pyridinylmethyl)-, (4R,5S,6S,7R)-
- 153182-95-7/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1-(2-naphthalenylmethyl)-4,7-bis(phenylmethyl )-3-(4-pyridinylmethyl)-, (4R,5S,6S,7R)-
- 153182-91-3/2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1-(2-naphthalenylmethyl)-4,7-bis(phenylmethyl )-, (4R,5S,6S,7R)-
- 153182-90-2/2H-1,3-Diazepin-2-one, 1-butylhexahydro-5,6-dihydroxy-3-(2-naphthalenylmethyl)-4,7-bis(phenyl methyl)-, (4R,5S,6S,7R)-